Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications M Gong, S Wen, T Nguyen, C Wang, J Jin, L Zhou Diabetes, Metabolic Syndrome and Obesity, 943-962, 2020 | 65 | 2020 |
Dapagliflozin activates neurons in the central nervous system and regulates cardiovascular activity by inhibiting SGLT-2 in mice T Nguyen, S Wen, M Gong, X Yuan, D Xu, C Wang, J Jin, L Zhou Diabetes, Metabolic Syndrome and Obesity, 2781-2799, 2020 | 58 | 2020 |
An overview of energy and metabolic regulation S Wen, C Wang, M Gong, L Zhou Science China Life Sciences 62, 771-790, 2019 | 45 | 2019 |
The role of SGLT2 inhibitor on the treatment of diabetic retinopathy W Sha, S Wen, L Chen, B Xu, T Lei, L Zhou Journal of diabetes research 2020 (1), 8867875, 2020 | 32 | 2020 |
The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy H Chen, X Huang, M Dong, S Wen, L Zhou, X Yuan Diabetes, Metabolic Syndrome and Obesity, 1541-1554, 2023 | 24 | 2023 |
Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data X Yuan, J Diao, A Du, S Wen, L Zhou, Y Pan Journal of Translational Medicine 18, 1-12, 2020 | 22 | 2020 |
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors MDSWL Zhou Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022 (15 …, 2022 | 21 | 2022 |
Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: A cross-sectional study from China X Yuan, S Ding, L Zhou, S Wen, A Du, J Diao Annals of Palliative Medicine 10 (7), 8169179-8168179, 2021 | 9 | 2021 |
An overview of similarities and differences in metabolic actions and effects of central nervous system between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium … S Wen, T Nguyen, M Gong, X Yuan, C Wang, J Jin, L Zhou Diabetes, Metabolic Syndrome and Obesity, 2955-2972, 2021 | 9 | 2021 |
Psoriasis exacerbates the state of insulin resistance in patients with type 2 diabetes S Wen, C Liu, Y Li, J Pan, T Nguyen, L Zhou Diabetes, Metabolic Syndrome and Obesity, 2389-2397, 2021 | 9 | 2021 |
Islet autoantibodies in the patients with sjogren’s syndrome and thyroid disease and risk of progression to latent autoimmune diabetes in adults: A case series S Wen, W Jiang, L Zhou Diabetes, Metabolic Syndrome and Obesity, 1025-1033, 2021 | 8 | 2021 |
The mechanism of sodium-glucose cotransporter-2 inhibitors in reducing uric acid in type 2 diabetes mellitus M Dong, H Chen, S Wen, Y Yuan, L Yang, D Xu, L Zhou Diabetes, Metabolic Syndrome and Obesity, 437-445, 2023 | 7 | 2023 |
The hypoglycemia associated autonomic failure triggered by exercise in the patients with “brittle” diabetes and the strategy for prevention Y Mao, S Wen, M Zhou, S Zhu, L Zhou Endocrine Journal 66 (9), 753-762, 2019 | 7 | 2019 |
The comparative study on the status of bone metabolism and thyroid function in diabetic patients with or without ketosis or ketoacidosis C Xu, M Gong, S Wen, M Zhou, Y Li, L Zhou Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 779-797, 2022 | 6 | 2022 |
Low TSH levels within euthyroid range could play a negative role on bone mineral density in postmenopausal women with type 2 diabetes C Liu, J Pan, S Wen, T Nguyen, D Xu, C Wang, X Yuan, Z Wen, L Zhou Diabetes, Metabolic Syndrome and Obesity, 2349-2355, 2021 | 6 | 2021 |
PolyMet-HA nanocomplexs regulates glucose uptake by inhibiting SHIP2 activity X Yuan, L Ding, J Diao, S Wen, C Xu, L Zhou, A Du Journal of Biomaterials Applications 35 (7), 849-856, 2021 | 5 | 2021 |
The Mechanism of Metabolic Influences on the Endogenous GLP‐1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus T Nguyen, M Gong, S Wen, X Yuan, C Wang, J Jin, L Zhou Journal of Diabetes Research 2020 (1), 4727390, 2020 | 5 | 2020 |
Effect of Intestinal Flora on Hyperuricemia-Induced Chronic Kidney Injury in Type 2 Diabetic Patients and the Therapeutic Mechanism of New Anti-Diabetic Prescription Medications W Yan, S Wen, L Zhou Diabetes, Metabolic Syndrome and Obesity, 3029-3044, 2023 | 4 | 2023 |
The neuronal and non-neuronal pathways of sodium-glucose cotransporter-2 inhibitor on body weight-loss and insulin resistance M Dong, H Chen, S Wen, Y Yuan, L Yang, Y Li, X Yuan, D Xu, L Zhou Diabetes, Metabolic Syndrome and Obesity, 425-435, 2023 | 4 | 2023 |
A pilot study of modified mini-clinical evaluation exercises (mini-CEX) in rotation students in the department of endocrinology Y He, S Wen, M Zhou, X Li, M Gong, L Zhou Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2031-2038, 2022 | 4 | 2022 |